心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

亚洲专家组声明：动态血压监测(ABPM)指南

2020-12-14 亚洲心血管专家小组（统称） J Clin Hypertens (Greenwich) . 2020 Dec 14.

动态血压监测

高血压是一个重要的公共卫生问题，因其与许多重大疾病有关，包括心血管疾病和卒中。动态血压监测(ABPM)是诊断高血压和评估24h血压的金标准，本文主要针对动态血压监测(ABPM)提供了关键信息和建议。

中文标题：

亚洲专家组声明：动态血压监测(ABPM)指南

英文标题：

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network

发布机构：

亚洲心血管专家小组（统称）

发布日期：

2020-12-14

简要介绍：

高血压是一个重要的公共卫生问题，因其与许多重大疾病有关，包括心血管疾病和卒中。动态血压监测(ABPM)是诊断高血压和评估24h血压的金标准，本文主要针对动态血压监测(ABPM)提供了关键信息和建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2019 亚洲专家组声明：动态血压监测(ABPM)指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fc5991c002033e03, title=亚洲专家组声明：动态血压监测(ABPM)指南, enTitle=Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network, guiderFrom=J Clin Hypertens (Greenwich) . 2020 Dec 14., authorId=0, author=, summary=高血压是一个重要的公共卫生问题，因其与许多重大疾病有关，包括心血管疾病和卒中。动态血压监测(ABPM)是诊断高血压和评估24h血压的金标准，本文主要针对动态血压监测(ABPM)提供了关键信息和建议。, cover=https://img.medsci.cn/20201230/1609343950938_2020535.jpg, journalId=0, articlesId=null, associationId=1580, associationName=亚洲心血管专家小组（统称）, associationIntro= , copyright=0, guiderPublishedTime=Mon Dec 14 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">高血压是一个重要的公共卫生问题，因其与许多重大疾病有关，包括心血管疾病和卒中。</span><span style="color: #373737;">动态血压监测(ABPM)是诊断高血压和评估24h血压的金标准，本文主要针对动态血压监测(ABPM)提供了关键信息和建议。</span></p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=17619, tagName=动态血压监测)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17619, guiderKeyword=动态血压监测, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4296, appHits=223, showAppHits=0, pcHits=1213, showPcHits=4073, likes=2, shares=18, comments=12, approvalStatus=1, publishedTime=Thu Dec 31 00:27:28 CST 2020, publishedTimeString=2020-12-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 30 23:59:17 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:22:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2019 亚洲专家组声明：动态血压监测(ABPM)指南.pdf)])
2019 亚洲专家组声明：动态血压监测(ABPM)指南.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199885, encodeId=30a2119988511, content=全部是英文的。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2026537702, createdName=ms8000000479903220, createdTime=Sun Mar 06 11:53:36 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195636, encodeId=1bbe1195636b7, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d776497270, createdName=ms8000000652250505, createdTime=Mon Feb 21 11:47:01 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051374, encodeId=1af110513e41c, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Wed Sep 15 08:05:40 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005378, encodeId=7eb710053e878, content=谢谢了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210213/f6efe772e64a4d43a4f84fa895d5563e/03b3c2b9f0cd4e128f02dd2ffc620743.jpg, createdBy=897d1605912, createdName=zhangwangwei, createdTime=Thu Aug 05 15:39:53 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962299, encodeId=194d962299cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9c32151050, createdName=152200efcbm, createdTime=Sun May 02 16:11:02 CST 2021, time=2021-05-02, status=1, ipAttribution=)]
    2022-03-06 ms8000000479903220

    全部是英文的。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199885, encodeId=30a2119988511, content=全部是英文的。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2026537702, createdName=ms8000000479903220, createdTime=Sun Mar 06 11:53:36 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195636, encodeId=1bbe1195636b7, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d776497270, createdName=ms8000000652250505, createdTime=Mon Feb 21 11:47:01 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051374, encodeId=1af110513e41c, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Wed Sep 15 08:05:40 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005378, encodeId=7eb710053e878, content=谢谢了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210213/f6efe772e64a4d43a4f84fa895d5563e/03b3c2b9f0cd4e128f02dd2ffc620743.jpg, createdBy=897d1605912, createdName=zhangwangwei, createdTime=Thu Aug 05 15:39:53 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962299, encodeId=194d962299cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9c32151050, createdName=152200efcbm, createdTime=Sun May 02 16:11:02 CST 2021, time=2021-05-02, status=1, ipAttribution=)]
    2022-02-21 ms8000000652250505

    挺好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199885, encodeId=30a2119988511, content=全部是英文的。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2026537702, createdName=ms8000000479903220, createdTime=Sun Mar 06 11:53:36 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195636, encodeId=1bbe1195636b7, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d776497270, createdName=ms8000000652250505, createdTime=Mon Feb 21 11:47:01 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051374, encodeId=1af110513e41c, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Wed Sep 15 08:05:40 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005378, encodeId=7eb710053e878, content=谢谢了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210213/f6efe772e64a4d43a4f84fa895d5563e/03b3c2b9f0cd4e128f02dd2ffc620743.jpg, createdBy=897d1605912, createdName=zhangwangwei, createdTime=Thu Aug 05 15:39:53 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962299, encodeId=194d962299cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9c32151050, createdName=152200efcbm, createdTime=Sun May 02 16:11:02 CST 2021, time=2021-05-02, status=1, ipAttribution=)]
    2021-09-15 j3x

    很有用！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199885, encodeId=30a2119988511, content=全部是英文的。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2026537702, createdName=ms8000000479903220, createdTime=Sun Mar 06 11:53:36 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195636, encodeId=1bbe1195636b7, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d776497270, createdName=ms8000000652250505, createdTime=Mon Feb 21 11:47:01 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051374, encodeId=1af110513e41c, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Wed Sep 15 08:05:40 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005378, encodeId=7eb710053e878, content=谢谢了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210213/f6efe772e64a4d43a4f84fa895d5563e/03b3c2b9f0cd4e128f02dd2ffc620743.jpg, createdBy=897d1605912, createdName=zhangwangwei, createdTime=Thu Aug 05 15:39:53 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962299, encodeId=194d962299cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9c32151050, createdName=152200efcbm, createdTime=Sun May 02 16:11:02 CST 2021, time=2021-05-02, status=1, ipAttribution=)]
    2021-08-05 zhangwangwei

    谢谢了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1199885, encodeId=30a2119988511, content=全部是英文的。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2026537702, createdName=ms8000000479903220, createdTime=Sun Mar 06 11:53:36 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195636, encodeId=1bbe1195636b7, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d776497270, createdName=ms8000000652250505, createdTime=Mon Feb 21 11:47:01 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051374, encodeId=1af110513e41c, content=很有用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Wed Sep 15 08:05:40 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005378, encodeId=7eb710053e878, content=谢谢了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210213/f6efe772e64a4d43a4f84fa895d5563e/03b3c2b9f0cd4e128f02dd2ffc620743.jpg, createdBy=897d1605912, createdName=zhangwangwei, createdTime=Thu Aug 05 15:39:53 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962299, encodeId=194d962299cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9c32151050, createdName=152200efcbm, createdTime=Sun May 02 16:11:02 CST 2021, time=2021-05-02, status=1, ipAttribution=)]
    2021-05-02 152200efcbm

    学习了

    0

相关指南

亚洲动态血压监测专家共识解读

暂未更新 · 2019-11-30

2019 亚洲专家组共识建议：动态血压监测

亚洲心血管专家小组（统称） · 2019-09-15

2015 动态血压监测临床应用中国专家共识

中国高血压联盟 · 2015-08-30

拓展阅读

2015 动态血压监测临床应用中国专家共识

中国高血压联盟 · 2015-08-30

2019 亚洲专家组共识建议：动态血压监测

亚洲心血管专家小组（统称） · 2019-09-15

亚洲动态血压监测专家共识解读

暂未更新 · 2019-11-30

2020中国动态血压监测指南

中国高血压联盟 · 2021-03-29

2022 AHA科学声明：儿童和青少年动态血压监测（更新版）

美国心脏协会(AHA,American Heart Association) · 2022-05-23

成人动态血压监测操作的证据总结

暂未更新 · 2024-12-09